Asset Dedication LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $93.2K | Buy |
490
+15
| +3% | +$2.58K | 0.01% | 411 |
|
|
2026
Q1 | $80.2K | Hold |
475
| – | – | 0.01% | 423 |
|
|
2025
Q4 | $80.2K | Buy |
475
+3
| +0.6% | +$487 | 0.01% | 427 |
|
|
2025
Q3 | $68.1K | Hold |
472
| – | – | ﹤0.01% | 472 |
|
|
2025
Q2 | $59.7K | Hold |
472
| – | – | ﹤0.01% | 493 |
|
|
2025
Q1 | $60.4K | Hold |
472
| – | – | ﹤0.01% | 455 |
|
|
2024
Q4 | $62.4K | Hold |
472
| – | – | ﹤0.01% | 439 |
|
|
2024
Q3 | $68.7K | Hold |
472
| – | – | ﹤0.01% | 460 |
|
|
2024
Q2 | $64.8K | Hold |
472
| – | – | ﹤0.01% | 457 |
|
|
2024
Q1 | $65K | Buy |
472
+342
| +263% | +$46.7K | ﹤0.01% | 409 |
|
|
2023
Q4 | $18K | Hold |
130
| – | – | ﹤0.01% | 593 |
|
|
2023
Q3 | $16K | Hold |
130
| – | – | ﹤0.01% | 602 |
|
|
2023
Q2 | $17K | Hold |
130
| – | – | ﹤0.01% | 587 |
|
|
2023
Q1 | $17K | Buy |
130
+30
| +30% | +$3.93K | ﹤0.01% | 580 |
|
|
2022
Q4 | $13K | Hold |
100
| – | – | ﹤0.01% | 619 |
|
|
2022
Q3 | $12K | Buy |
+100
| New | +$12.4K | ﹤0.01% | 596 |
|
|
2022
Q2 | – | Sell |
-100
| Closed | -$13K | – | 694 |
|
|
2022
Q1 | $13K | Hold |
100
| – | – | ﹤0.01% | 622 |
|
|
2021
Q4 | $15K | Hold |
100
| – | – | ﹤0.01% | 590 |
|
|
2021
Q3 | $16K | Hold |
100
| – | – | ﹤0.01% | 605 |
|
|
2021
Q2 | $16K | Hold |
100
| – | – | ﹤0.01% | 554 |
|
|
2021
Q1 | $15K | Hold |
100
| – | – | ﹤0.01% | 460 |
|
|
2020
Q4 | $15K | Sell |
100
-50
| -33% | -$7.15K | ﹤0.01% | 496 |
|
|
2020
Q3 | $20K | Sell |
150
-657
| -81% | -$89.1K | ﹤0.01% | 447 |
|
|
2020
Q2 | $111K | Sell |
807
-146
| -15% | -$18.6K | 0.03% | 251 |
|
|
2020
Q1 | $103K | Buy |
953
+53
| +6% | +$6.1K | 0.03% | 254 |
|
|
2019
Q4 | $108K | Hold |
900
| – | – | 0.03% | 233 |
|
|
2019
Q3 | $89K | Hold |
900
| – | – | 0.03% | 234 |
|
|
2019
Q2 | $99K | Hold |
900
| – | – | 0.03% | 223 |
|
|
2019
Q1 | $100K | Hold |
900
| – | – | 0.03% | 215 |
|
|
2018
Q4 | $86K | Hold |
900
| – | – | 0.04% | 212 |
|
|
2018
Q3 | $110K | Hold |
900
| – | – | 0.04% | 193 |
|
|
2018
Q2 | $99K | Hold |
900
| – | – | 0.03% | 209 |
|
|
2018
Q1 | $96K | Hold |
900
| – | – | 0.05% | 178 |
|
|
2017
Q4 | $96K | Hold |
900
| – | – | 0.04% | 183 |
|
|
2017
Q3 | $100K | Hold |
900
| – | – | 0.05% | 159 |
|
|
2017
Q2 | $93K | Hold |
900
| – | – | 0.05% | 169 |
|
|
2017
Q1 | $88K | Hold |
900
| – | – | 0.05% | 168 |
|
|
2016
Q4 | $79K | Sell |
900
-333
| -27% | -$30.3K | 0.05% | 173 |
|
|
2016
Q3 | $118K | Buy |
1,233
+333
| +37% | +$31.7K | 0.07% | 145 |
|
|
2016
Q2 | $77K | Hold |
900
| – | – | 0.05% | 166 |
|
|
2016
Q1 | $78K | Sell |
900
-1,683
| -65% | -$151K | 0.06% | 152 |
|
|
2015
Q4 | $291K | Buy |
+2,583
| New | +$280K | 0.19% | 117 |
|
Other funds holding IBB
CB
Asset Dedication LLC's IBB Position: Q2 2026 in Review
Asset Dedication LLC increased its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2026, buying an estimated $2.58K and bringing the position to 490 shares worth $93.2K. The position accounts for 0.01% of the portfolio, ranked #411.
Asset Dedication LLC first reported a position in IBB in Q4 2015 and has held it in 42 quarters since. The position peaked at $291K in Q4 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Asset Dedication LLC held 490 shares of iShares Biotechnology ETF worth $93.2K as of Q2 2026.
- Asset Dedication LLC bought 15 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.58K.
- iShares Biotechnology ETF made up 0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #411 holding.
- Asset Dedication LLC first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 42 quarters since.
- Asset Dedication LLC's iShares Biotechnology ETF position peaked at $291K in Q4 2015.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.